A look inside the very risky bet that has suddenly made the Serum Institute CEO Indian healthcare’s new, controversial poster boy.
Till just a year ago, the easiest place to find Adar Poonawalla was on page three of the Pune newspaper supplements. Though he ran the world’s largest vaccine manufacturing business, he was more likely to be seen in the company of Bollywood stars and was best known for an extravagance that only copious amounts of old money could afford. His father, Cyrus, consistently ranked among the top 15 billionaires in the country, even though the privately held Serum’s annual revenues of about $1 billion, or Rs 7,500 crore, didn’t qualify it to be among the top 100 businesses in the …
Surendar helps lead the newsroom at The Morning Context as executive editor. Over the years, Surendar has worked in industries from pharmaceuticals to diamonds, as well as a stint as an equity analyst. In his long career as a business journalist, he has led teams at The Times of India, India Today and Fortune India. He was part of the founding team at Forbes India and interned at and published in The Times, London.
Executive Editor
surendar@mailtmc.com
Mumbai